Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Beyer

Showing results (1-10 of 225) with videos related to

Pageof 23
Sort By:
Blood|March 25, 2021
Checkpoint inhibitors and thrombosis: what's up?Jan Beyer-Westendorf
Deutsches Arzteblatt International|August 2, 2019
In ReplyJan Beyer-Westendorf
Thrombosis Research|December 29, 2016
Letter to the Editor "Gender related aspects of bleeding with rivaroxaban in venous thromboembolism - Potential for pitfalls": A comment to "Impact of gender on safety and efficacy of rivaroxaban in adolescents & young adults with venous thromboembolism" by Manuela Krause et al. (Thrombosis Research 2016, published online)Jan Beyer-Westendorf
Thrombosis Research|February 7, 2018
What have we learned from real-world NOAC studies in venous thromboembolism treatment?Jan Beyer-Westendorf
Deutsche Medizinische Wochenschrift (1946)|February 7, 2015
[Bleeding complications under oral anticoagulation]Jan Beyer-Westendorf
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 1, 2016
Independent data about the safety and efficacy of rivaroxaban for prevention of stroke/embolism are needed: Author replyJan Beyer-Westendorf
Thrombosis and Haemostasis|July 3, 2009
Safety of venous ultrasound in suspected DVT--still a matter of concern?Jan Beyer-Westendorf
Hamostaseologie|February 15, 2021
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining IssuesJan Beyer-Westendorf
Hematology. American Society of Hematology. Education Program|December 10, 2017
Controversies in venous thromboembolism: to treat or not to treat superficial vein thrombosisJan Beyer-Westendorf
Thrombosis Research|September 4, 2019
DOACS in women: pros and consJan Beyer-Westendorf
Pageof 23

Showing results (1-10 of 225) with videos related to

Sort By:
Pageof 23
Blood|March 25, 2021
Checkpoint inhibitors and thrombosis: what's up?Jan Beyer-Westendorf
Deutsches Arzteblatt International|August 2, 2019
In ReplyJan Beyer-Westendorf
Thrombosis Research|December 29, 2016
Letter to the Editor "Gender related aspects of bleeding with rivaroxaban in venous thromboembolism - Potential for pitfalls": A comment to "Impact of gender on safety and efficacy of rivaroxaban in adolescents & young adults with venous thromboembolism" by Manuela Krause et al. (Thrombosis Research 2016, published online)Jan Beyer-Westendorf
Thrombosis Research|February 7, 2018
What have we learned from real-world NOAC studies in venous thromboembolism treatment?Jan Beyer-Westendorf
Deutsche Medizinische Wochenschrift (1946)|February 7, 2015
[Bleeding complications under oral anticoagulation]Jan Beyer-Westendorf
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 1, 2016
Independent data about the safety and efficacy of rivaroxaban for prevention of stroke/embolism are needed: Author replyJan Beyer-Westendorf
Thrombosis and Haemostasis|July 3, 2009
Safety of venous ultrasound in suspected DVT--still a matter of concern?Jan Beyer-Westendorf
Hamostaseologie|February 15, 2021
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining IssuesJan Beyer-Westendorf
Hematology. American Society of Hematology. Education Program|December 10, 2017
Controversies in venous thromboembolism: to treat or not to treat superficial vein thrombosisJan Beyer-Westendorf
Thrombosis Research|September 4, 2019
DOACS in women: pros and consJan Beyer-Westendorf
Pageof 23